CAITLIN MCMAHON: Open Payments
NPI 1679100028 · CAMDEN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$478 in 17 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $194 · 2025 $478
Food & beverage: $478
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $248 |
| Verona Pharma, Inc. | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 4 | $72 |
| United Therapeutics Corporation | 2 | $35 |
| GENZYME CORPORATION | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: BREZTRI, DUPIXENT, Ohtuvayre, Tyvaso, FASENRA, NUCALA, Adempas.
Industry payments across NJ — which companies pay providers there.
